Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
(+-)-tetrahydropalmatine + Idarubicin
|
DCVY03J
|
(+-)-tetrahydropalmatine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
10-hydroxycamptothecin + Idarubicin
|
DCV5BK9
|
10-hydroxycamptothecin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
16,16-dimethyl-PGE2 + Idarubicin
|
DC7X9LN
|
16,16-dimethyl-PGE2
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
3,4-Dihydroxycinnamic Acid + Idarubicin
|
DCTQVJP
|
3,4-Dihydroxycinnamic Acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
3,7,3',4'-TETRAHYDROXYFLAVONE + Idarubicin
|
DC2X0PS
|
3,7,3',4'-TETRAHYDROXYFLAVONE
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
5-Fluoro-2-deoxycytidine + Idarubicin
|
DC4YEUP
|
5-Fluoro-2-deoxycytidine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
6-bromoindirubin-3-oxime + Idarubicin
|
DC06JV3
|
6-bromoindirubin-3-oxime
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
8-chloro-adenosine + Idarubicin
|
DCAI59B
|
8-chloro-adenosine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
A-674563 + Idarubicin
|
DC3IHBR
|
A-674563
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
ABIRATERONE + Idarubicin
|
DCIB03Q
|
ABIRATERONE
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
ABIRATERONE + Idarubicin
|
DCWIRS1
|
ABIRATERONE
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
ABIRATERONE + Idarubicin
|
DCTIXQL
|
ABIRATERONE
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Acadesine + Idarubicin
|
DCHHLUG
|
Acadesine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Acamprosate + Idarubicin
|
DCMHLF2
|
Acamprosate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Acemetacin + Idarubicin
|
DCKTN1L
|
Acemetacin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Acetazolamide + Idarubicin
|
DC2MWY7
|
Acetazolamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Acetohydroxamic Acid + Idarubicin
|
DCN9JQQ
|
Acetohydroxamic Acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Aciclovir + Idarubicin
|
DC6641V
|
Aciclovir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Acitretin + Idarubicin
|
DCHV5KZ
|
Acitretin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Acitretin + Idarubicin
|
DCDVCHS
|
Acitretin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
ADS-5102 + Idarubicin
|
DC6OH3X
|
ADS-5102
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AEW-541 + Idarubicin
|
DCVH2PC
|
AEW-541
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AG-881 + Idarubicin
|
DC4XKLL
|
AG-881
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Aliskiren + Idarubicin
|
DCIGMDO
|
Aliskiren
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Allopurinol + Idarubicin
|
DCF0ELW
|
Allopurinol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Aloe-emodin + Idarubicin
|
DCHZW1T
|
Aloe-emodin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AMG 900 + Idarubicin
|
DC1WSIC
|
AMG 900
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Amiloride + Idarubicin
|
DCA1FJ9
|
Amiloride
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Aminosalicylic acid + Idarubicin
|
DCORUMC
|
Aminosalicylic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Amlexanox + Idarubicin
|
DC04MGQ
|
Amlexanox
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Amodiaquine + Idarubicin
|
DCZWU04
|
Amodiaquine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Amonafide + Idarubicin
|
DCG8CLU
|
Amonafide
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Amonafide + Idarubicin
|
DCGCFR4
|
Amonafide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Anacetrapib + Idarubicin
|
DCIUDLY
|
Anacetrapib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Anamorelin + Idarubicin
|
DCAXLP3
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Anastrozole + Idarubicin
|
DCRBX8J
|
Anastrozole
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
Anastrozole + Idarubicin
|
DCOHP4I
|
Anastrozole
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
Anastrozole + Idarubicin
|
DCFNUWN
|
Anastrozole
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
Anastrozole + Idarubicin
|
DCVJSE5
|
Anastrozole
|
Glioma (Cell Line: SF-268)
|
[3] |
Anastrozole + Idarubicin
|
DC7BWI7
|
Anastrozole
|
Melanoma (Cell Line: UACC-257)
|
[3] |
Anastrozole + Idarubicin
|
DCGXZRL
|
Anastrozole
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Anastrozole + Idarubicin
|
DCFEB0X
|
Anastrozole
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Antimycin A + Idarubicin
|
DC11TPR
|
Antimycin A
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Aprepitant + Idarubicin
|
DC3ZQN2
|
Aprepitant
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AR-12 + Idarubicin
|
DCQL7KG
|
AR-12
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AR-42 + Idarubicin
|
DCC3UGM
|
AR-42
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Arbidol + Idarubicin
|
DCQBU5W
|
Arbidol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Arfolitixorin + Idarubicin
|
DC4372C
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Artemisinin + Idarubicin
|
DC70SU9
|
Artemisinin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AS-604850 + Idarubicin
|
DCDTMDB
|
AS-604850
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Asenapine + Idarubicin
|
DCL1W3T
|
Asenapine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AST-1306 + Idarubicin
|
DC41TO3
|
AST-1306
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
AT13387 + Idarubicin
|
DC9ZPZR
|
AT13387
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Atovaquone + Idarubicin
|
DCQ6KOX
|
Atovaquone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Auranofin + Idarubicin
|
DCPYMXS
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
AZD1208 + Idarubicin
|
DC6SDBP
|
AZD1208
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Azelnidipine + Idarubicin
|
DCS5OLC
|
Azelnidipine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Azithromycin + Idarubicin
|
DC81WOB
|
Azithromycin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Aztreonam + Idarubicin
|
DCGDI0P
|
Aztreonam
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BAICALEIN + Idarubicin
|
DCF4RLT
|
BAICALEIN
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Bardoxolone methyl + Idarubicin
|
DCSIUXA
|
Bardoxolone methyl
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Basmisanil + Idarubicin
|
DCS2IM9
|
Basmisanil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BAY-57-9352 + Idarubicin
|
DCK09CL
|
BAY-57-9352
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Belnacasan + Idarubicin
|
DCXPORN
|
Belnacasan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Bepridil + Idarubicin
|
DCKENL9
|
Bepridil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Betaxolol + Idarubicin
|
DCH9TK0
|
Betaxolol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BHV-0223 + Idarubicin
|
DCVCPD6
|
BHV-0223
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BI-D1870 + Idarubicin
|
DC8JH38
|
BI-D1870
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Bicalutamide + Idarubicin
|
DCUT5EA
|
Bicalutamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Bilobalide + Idarubicin
|
DCGGRVM
|
Bilobalide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BIO-300 + Idarubicin
|
DCUI1Z5
|
BIO-300
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
BIO-300 + Idarubicin
|
DCZ28OB
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Birinapant + Idarubicin
|
DCX1PK4
|
Birinapant
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BMS-265246 + Idarubicin
|
DCHNGFE
|
BMS-265246
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BMS-345541 + Idarubicin
|
DC54HPJ
|
BMS-345541
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BMS-754807 + Idarubicin
|
DCOWVAM
|
BMS-754807
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BMS-777607 + Idarubicin
|
DCE1GD8
|
BMS-777607
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BMS-833923 + Idarubicin
|
DCZ2BXS
|
BMS-833923
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Bortezomib + Idarubicin
|
DCEJVXK
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Bortezomib + Idarubicin
|
DC58HZM
|
Bortezomib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Bosentan + Idarubicin
|
DCK7ORX
|
Bosentan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
BQ-123 + Idarubicin
|
DCXC5XG
|
BQ-123
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Brincidofovir + Idarubicin
|
DC0UH5T
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
BRL-15572 + Idarubicin
|
DCKYOEN
|
BRL-15572
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
BTZ-043 + Idarubicin
|
DC5NB67
|
BTZ-043
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Busulfan + Idarubicin
|
DCJBRB5
|
Busulfan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Busulfan + Idarubicin
|
DCNN559
|
Busulfan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cabazitaxel + Idarubicin
|
DC9PUJM
|
Cabazitaxel
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cabazitaxel + Idarubicin
|
DCSTWJ9
|
Cabazitaxel
|
Glioma (Cell Line: SF-539)
|
[3] |
Cabazitaxel + Idarubicin
|
DC2X9ZS
|
Cabazitaxel
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
Cabozantinib + Idarubicin
|
DC27LYP
|
Cabozantinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Carglumic acid + Idarubicin
|
DCGFJMU
|
Carglumic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Carvedilol + Idarubicin
|
DCUXCY2
|
Carvedilol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CBLC137 + Idarubicin
|
DC8AV73
|
CBLC137
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CC-486 + Idarubicin
|
DC5MSB5
|
CC-486
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cefaclor + Idarubicin
|
DCNH6X0
|
Cefaclor
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cefmenoxime + Idarubicin
|
DCYE7CH
|
Cefmenoxime
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Cefmenoxime + Idarubicin
|
DCF7EZG
|
Cefmenoxime
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CEP-32496 + Idarubicin
|
DC5IA2A
|
CEP-32496
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CF102 + Idarubicin
|
DC0DECY
|
CF102
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CGS 21680 + Idarubicin
|
DCEEPMU
|
CGS 21680
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Chloroquine + Idarubicin
|
DCNQ9IH
|
Chloroquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Chlorothiazide + Idarubicin
|
DC0SDYL
|
Chlorothiazide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Chloroxine + Idarubicin
|
DCANSBZ
|
Chloroxine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Chlorzoxazone + Idarubicin
|
DCI6KRP
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Cholic acid + Idarubicin
|
DCAVXL9
|
Cholic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CI-966 + Idarubicin
|
DCM0QFP
|
CI-966
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ciclesonide + Idarubicin
|
DC8TK4V
|
Ciclesonide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cidofovir + Idarubicin
|
DCNMDJ2
|
Cidofovir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cilengitide + Idarubicin
|
DCP1AKR
|
Cilengitide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cinaciguat + Idarubicin
|
DCHF8EL
|
Cinaciguat
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cisatracurium + Idarubicin
|
DCZ7MC3
|
Cisatracurium
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Cladribine + Idarubicin
|
DCCOL2D
|
Cladribine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clascoterone + Idarubicin
|
DCOKUXP
|
Clascoterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Clascoterone + Idarubicin
|
DCUYZ5D
|
Clascoterone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clemastine + Idarubicin
|
DCIQYXL
|
Clemastine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clofarabine + Idarubicin
|
DCBYSKM
|
Clofarabine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clofibrate + Idarubicin
|
DCBO84A
|
Clofibrate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clonidine + Idarubicin
|
DCL7I1P
|
Clonidine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clopidogrel + Idarubicin
|
DCETDSR
|
Clopidogrel
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Clotrimazole + Idarubicin
|
DCE9UDY
|
Clotrimazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Coenzyme Q10 + Idarubicin
|
DCM540K
|
Coenzyme Q10
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CP-724714 + Idarubicin
|
DC1NJBO
|
CP-724714
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CP-868596 + Idarubicin
|
DC0PQFL
|
CP-868596
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Crisaborole + Idarubicin
|
DCL0EFL
|
Crisaborole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Crizotinib + Idarubicin
|
DCMVTQY
|
Crizotinib
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
Crizotinib + Idarubicin
|
DC58TE8
|
Crizotinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CT-064 + Idarubicin
|
DCHNIZW
|
CT-064
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
CUDC-101 + Idarubicin
|
DCB28DP
|
CUDC-101
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Curcumin + Idarubicin
|
DCCB4TV
|
Curcumin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC1HI6P
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: CAOV3)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC41ESM
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCKPPQ2
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: A427)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCVFZEH
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCE5ETU
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: NCIH520)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC5GU7Z
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: DLD1)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCWHO5J
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCZ16T5
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCHCUG5
|
Cyclophosphamide
|
Amelanotic melanoma (Cell Line: A2058)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC7RJ1Y
|
Cyclophosphamide
|
Germ cell tumour (Cell Line: PA1)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCM2OSN
|
Cyclophosphamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCRJ3K8
|
Cyclophosphamide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCEO0XD
|
Cyclophosphamide
|
Malignant melanoma (Cell Line: A375)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCSBJFK
|
Cyclophosphamide
|
Malignant melanoma (Cell Line: HT144)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC8KC3T
|
Cyclophosphamide
|
Malignant melanoma (Cell Line: SKMEL30)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC4B3AX
|
Cyclophosphamide
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCJ4VV8
|
Cyclophosphamide
|
Malignant melanoma (Cell Line: RPMI7951)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCPUSBN
|
Cyclophosphamide
|
Mesothelioma (Cell Line: MSTO)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCPCDLA
|
Cyclophosphamide
|
Non small cell carcinoma (Cell Line: SKMES1)
|
[3] |
Cyclophosphamide + Idarubicin
|
DC93USR
|
Cyclophosphamide
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCLRQFN
|
Cyclophosphamide
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCUK17Z
|
Cyclophosphamide
|
Prostate carcinoma (Cell Line: LNCAP)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCE7XAP
|
Cyclophosphamide
|
Prostate carcinoma (Cell Line: VCAP)
|
[3] |
Cyclophosphamide + Idarubicin
|
DCJ36KA
|
Cyclophosphamide
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289)
|
[4] |
Cyclophosphamide + Idarubicin
|
DC1H24L
|
Cyclophosphamide
|
Breast carcinoma (Cell Line: ZR751)
|
[4] |
Cyclophosphamide + Idarubicin
|
DCM4YTV
|
Cyclophosphamide
|
Breast carcinoma (Cell Line: KPL1)
|
[4] |
Cyclophosphamide + Idarubicin
|
DCQWQHL
|
Cyclophosphamide
|
Breast carcinoma (Cell Line: OCUBM)
|
[4] |
Cyclophosphamide + Idarubicin
|
DCWVL11
|
Cyclophosphamide
|
Carcinoma (Cell Line: EFM192B)
|
[4] |
Cyclophosphamide + Idarubicin
|
DC5989Y
|
Cyclophosphamide
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Cyclophosphamide + Idarubicin
|
DC1GROU
|
Cyclophosphamide
|
Colon adenocarcinoma (Cell Line: LOVO)
|
[4] |
Cyclophosphamide + Idarubicin
|
DCSKXS9
|
Cyclophosphamide
|
Colon carcinoma (Cell Line: RKO)
|
[4] |
Cyclophosphamide + Idarubicin
|
DCW2U0C
|
Cyclophosphamide
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Cyclosporin A + Idarubicin
|
DCAATS9
|
Cyclosporin A
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Cytarabine + Idarubicin
|
DCYB9WQ
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Dacarbazine + Idarubicin
|
DCRIO9D
|
Dacarbazine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Dacarbazine + Idarubicin
|
DC02IWX
|
Dacarbazine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dacarbazine + Idarubicin
|
DCC3LKH
|
Dacarbazine
|
Glioma (Cell Line: SF-268)
|
[3] |
Dacarbazine + Idarubicin
|
DC0ISQV
|
Dacarbazine
|
Glioma (Cell Line: SF-295)
|
[3] |
Dacarbazine + Idarubicin
|
DCYPK0H
|
Dacarbazine
|
Melanoma (Cell Line: UACC-257)
|
[3] |
Dacarbazine + Idarubicin
|
DCBXNJ3
|
Dacarbazine
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
Dacomitinib + Idarubicin
|
DCLWJ1O
|
Dacomitinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dactinomycin + Idarubicin
|
DCT95V5
|
Dactinomycin
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Dactinomycin + Idarubicin
|
DCMKHVM
|
Dactinomycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Dactinomycin + Idarubicin
|
DC04UOP
|
Dactinomycin
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[5] |
Daio-Orengedokuto (DOT) + Idarubicin
|
DCLY6NV
|
Daio-Orengedokuto (DOT)
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dalcetrapib + Idarubicin
|
DCKBH7Z
|
Dalcetrapib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dantrolene + Idarubicin
|
DC7ND7W
|
Dantrolene
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Darunavir + Idarubicin
|
DCPATPU
|
Darunavir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dasatinib + Idarubicin
|
DCC4HA2
|
Dasatinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Deferasirox + Idarubicin
|
DC41RXC
|
Deferasirox
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Deflazacort + Idarubicin
|
DCURQ3M
|
Deflazacort
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Desoxycorticosterone pivalate + Idarubicin
|
DC1R8ZS
|
Desoxycorticosterone pivalate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Dexamethasone + Idarubicin
|
DCVI8ZX
|
Dexamethasone
|
Breast carcinoma (Cell Line: KPL1)
|
[4] |
Dexamethasone + Idarubicin
|
DC8O7KB
|
Dexamethasone
|
Breast carcinoma (Cell Line: OCUBM)
|
[4] |
Dexamethasone + Idarubicin
|
DCWCWU0
|
Dexamethasone
|
Carcinoma (Cell Line: EFM192B)
|
[4] |
Dexamethasone + Idarubicin
|
DCAP87Q
|
Dexamethasone
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Dexamethasone + Idarubicin
|
DCSY83A
|
Dexamethasone
|
Colon adenocarcinoma (Cell Line: LOVO)
|
[4] |
Dexamethasone + Idarubicin
|
DCY4MF9
|
Dexamethasone
|
Colon carcinoma (Cell Line: RKO)
|
[4] |
Dexamethasone + Idarubicin
|
DCOS1H7
|
Dexamethasone
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Dexamethasone + Idarubicin
|
DCNFRJ0
|
Dexamethasone
|
Adenocarcinoma (Cell Line: NCIH520)
|
[5] |
Dexamethasone + Idarubicin
|
DCLVMMX
|
Dexamethasone
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Dexamethasone + Idarubicin
|
DC3096L
|
Dexamethasone
|
Adenocarcinoma (Cell Line: DLD1)
|
[5] |
Dexamethasone + Idarubicin
|
DC981EM
|
Dexamethasone
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Dexamethasone + Idarubicin
|
DC1G4GJ
|
Dexamethasone
|
Germ cell tumour (Cell Line: PA1)
|
[5] |
Dexamethasone + Idarubicin
|
DCGC0JJ
|
Dexamethasone
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Dexamethasone + Idarubicin
|
DCMWQHM
|
Dexamethasone
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Dexamethasone + Idarubicin
|
DCPMA9S
|
Dexamethasone
|
Malignant melanoma (Cell Line: SKMEL30)
|
[5] |
Dexamethasone + Idarubicin
|
DCZMIT4
|
Dexamethasone
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Dexamethasone + Idarubicin
|
DCHJ8ZA
|
Dexamethasone
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
Dexamethasone + Idarubicin
|
DCQSRQD
|
Dexamethasone
|
Prostate carcinoma (Cell Line: VCAP)
|
[5] |
Dexamethasone + Idarubicin
|
DC1F8BN
|
Dexamethasone
|
Prostate carcinoma (Cell Line: LNCAP)
|
[5] |
Dexanabinol + Idarubicin
|
DCPNTNX
|
Dexanabinol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dexrazoxane + Idarubicin
|
DCIMVC4
|
Dexrazoxane
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
DFN-15 + Idarubicin
|
DCDZI1K
|
DFN-15
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
DFN-15 + Idarubicin
|
DCTRN7K
|
DFN-15
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
DFN-15 + Idarubicin
|
DCVJANQ
|
DFN-15
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
DFN-15 + Idarubicin
|
DC7QM1P
|
DFN-15
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
DFN-15 + Idarubicin
|
DC0PKSU
|
DFN-15
|
Carcinoma (Cell Line: MCF7)
|
[4] |
DFN-15 + Idarubicin
|
DCUXW38
|
DFN-15
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
DFN-15 + Idarubicin
|
DCID8XB
|
DFN-15
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
DFN-15 + Idarubicin
|
DC9WVLQ
|
DFN-15
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
DFN-15 + Idarubicin
|
DCE0OYX
|
DFN-15
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
DFN-15 + Idarubicin
|
DC4CM9K
|
DFN-15
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
DFN-15 + Idarubicin
|
DCKMVPF
|
DFN-15
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
DFN-15 + Idarubicin
|
DCSZCNT
|
DFN-15
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
DFN-15 + Idarubicin
|
DCYX5N0
|
DFN-15
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
Diazoxide + Idarubicin
|
DCZFTIY
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Didanosine + Idarubicin
|
DCWN1HI
|
Didanosine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dienestrol + Idarubicin
|
DCEZ944
|
Dienestrol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Digitoxin + Idarubicin
|
DCZXXQ2
|
Digitoxin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
Digoxin + Idarubicin
|
DCCXL3V
|
Digoxin
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Dioscin + Idarubicin
|
DCW18N3
|
Dioscin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Diosmin + Idarubicin
|
DC3BTUN
|
Diosmin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Disulfiram + Idarubicin
|
DCVGATN
|
Disulfiram
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Docetaxel + Idarubicin
|
DCCPWO5
|
Docetaxel
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Docosanol + Idarubicin
|
DCKMGJS
|
Docosanol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Doxifluridine + Idarubicin
|
DCCYE0V
|
Doxifluridine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Doxorubicin + Idarubicin
|
DC3H0I2
|
Doxorubicin
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
Doxorubicin + Idarubicin
|
DCFAJLH
|
Doxorubicin
|
Mesothelioma (Cell Line: MSTO)
|
[3] |
Doxorubicin + Idarubicin
|
DCAUCE0
|
Doxorubicin
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[3] |
Drospirenone + Idarubicin
|
DCOUVMO
|
Drospirenone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
DTI-015 + Idarubicin
|
DC41X9E
|
DTI-015
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Dyphylline + Idarubicin
|
DCV4DEE
|
Dyphylline
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Econail + Idarubicin
|
DC8G9G8
|
Econail
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Eflornithine + Idarubicin
|
DC4UWBA
|
Eflornithine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
ELLAGIC ACID + Idarubicin
|
DC9QRQI
|
ELLAGIC ACID
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Emetine + Idarubicin
|
DC0DEAD
|
Emetine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Emodin + Idarubicin
|
DCK3TK6
|
Emodin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Emtricitabine + Idarubicin
|
DCJNT9D
|
Emtricitabine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Endoxifen + Idarubicin
|
DCPVBNM
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Enoxacin + Idarubicin
|
DC5TQ0C
|
Enoxacin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Epinephrine + Idarubicin
|
DCBFI80
|
Epinephrine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Epirubicin + Idarubicin
|
DCU56D5
|
Epirubicin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Epirubicin + Idarubicin
|
DC7318N
|
Epirubicin
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
Epirubicin + Idarubicin
|
DCKWUAU
|
Epirubicin
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Epirubicin + Idarubicin
|
DC62KEV
|
Epirubicin
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Epirubicin + Idarubicin
|
DC6AP70
|
Epirubicin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Epirubicin + Idarubicin
|
DCAVX31
|
Epirubicin
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
Epothilone D + Idarubicin
|
DCXWING
|
Epothilone D
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Erdosteine + Idarubicin
|
DC6HVOD
|
Erdosteine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Erteberel + Idarubicin
|
DC4FP4P
|
Erteberel
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Estramustine + Idarubicin
|
DCFPOMS
|
Estramustine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Estramustine + Idarubicin
|
DCGW8SB
|
Estramustine
|
Breast carcinoma (Cell Line: KPL1)
|
[4] |
Estramustine + Idarubicin
|
DCJJK8P
|
Estramustine
|
Colon carcinoma (Cell Line: RKO)
|
[4] |
Estramustine + Idarubicin
|
DCBDOSY
|
Estramustine
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Estramustine + Idarubicin
|
DCHB0XM
|
Estramustine
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Estramustine + Idarubicin
|
DC0K9PN
|
Estramustine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[5] |
Estramustine + Idarubicin
|
DC4P7OI
|
Estramustine
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
Estramustine + Idarubicin
|
DCNQNLZ
|
Estramustine
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Estramustine + Idarubicin
|
DCUD52V
|
Estramustine
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Estramustine + Idarubicin
|
DCVUMXN
|
Estramustine
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Estramustine + Idarubicin
|
DCS8VOP
|
Estramustine
|
Prostate carcinoma (Cell Line: VCAP)
|
[5] |
Ethambutol + Idarubicin
|
DC76903
|
Ethambutol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Ethinyl estradiol + Idarubicin
|
DCQQYTQ
|
Ethinyl estradiol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
ETHISTERONE + Idarubicin
|
DCT30BQ
|
ETHISTERONE
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Etomidate + Idarubicin
|
DCCXGKV
|
Etomidate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Etonogestrel + Idarubicin
|
DC08AVS
|
Etonogestrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Etoposide + Idarubicin
|
DCHXGNQ
|
Etoposide
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
Etoposide + Idarubicin
|
DCLOVGJ
|
Etoposide
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[3] |
Etoposide + Idarubicin
|
DC06LL9
|
Etoposide
|
Amelanotic melanoma (Cell Line: A2058)
|
[3] |
Etoposide + Idarubicin
|
DCG40UT
|
Etoposide
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Etoposide + Idarubicin
|
DCBDV3I
|
Etoposide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Etoposide + Idarubicin
|
DCVTL32
|
Etoposide
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
Etoposide + Idarubicin
|
DCNCD8M
|
Etoposide
|
Mesothelioma (Cell Line: MSTO)
|
[3] |
Etoposide + Idarubicin
|
DCMQP4X
|
Etoposide
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[3] |
Ezetimibe + Idarubicin
|
DC53V20
|
Ezetimibe
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Famotidine + Idarubicin
|
DCRRHA3
|
Famotidine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Fibrates + Idarubicin
|
DCWQT47
|
Fibrates
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Flavonoid derivative 1 + Idarubicin
|
DC2FER3
|
Flavonoid derivative 1
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Floxuridine + Idarubicin
|
DC92FFA
|
Floxuridine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Flucytosine + Idarubicin
|
DC638RX
|
Flucytosine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Flumazenil + Idarubicin
|
DCFU7JW
|
Flumazenil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Flunarizine + Idarubicin
|
DCNJ8G6
|
Flunarizine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Fluorouracil + Idarubicin
|
DC9QC0E
|
Fluorouracil
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Fluorouracil + Idarubicin
|
DCKS576
|
Fluorouracil
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Fluorouracil + Idarubicin
|
DCOZD4A
|
Fluorouracil
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Fluorouracil + Idarubicin
|
DCYUGOD
|
Fluorouracil
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Fluorouracil + Idarubicin
|
DCMJH9X
|
Fluorouracil
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Fluorouracil + Idarubicin
|
DCJ0TFY
|
Fluorouracil
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Fluorouracil + Idarubicin
|
DCWGBQB
|
Fluorouracil
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Fluorouracil + Idarubicin
|
DCP73WX
|
Fluorouracil
|
Malignant melanoma (Cell Line: HT144)
|
[5] |
Fluorouracil + Idarubicin
|
DC0HO1F
|
Fluorouracil
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Fluorouracil + Idarubicin
|
DC7N28I
|
Fluorouracil
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Flurbiprofen + Idarubicin
|
DC6PK2P
|
Flurbiprofen
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Fluticasone propionate + Idarubicin
|
DCWMQ51
|
Fluticasone propionate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Fomepizole + Idarubicin
|
DCALXG1
|
Fomepizole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Fomepizole + Idarubicin
|
DCCUYMV
|
Fomepizole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
FORMESTANE + Idarubicin
|
DCAFMCN
|
FORMESTANE
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Fostemsavir + Idarubicin
|
DC32TXA
|
Fostemsavir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Fulvestrant + Idarubicin
|
DC69KIW
|
Fulvestrant
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Gallamine Triethiodide + Idarubicin
|
DCZGIWG
|
Gallamine Triethiodide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Gatifloxacin + Idarubicin
|
DCULN8V
|
Gatifloxacin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GDC-0152 + Idarubicin
|
DCNN6AD
|
GDC-0152
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Gefitinib + Idarubicin
|
DCMIVGE
|
Gefitinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Gefitinib + Idarubicin
|
DCU9MGE
|
Gefitinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Gemcitabine + Idarubicin
|
DC808JH
|
Gemcitabine
|
Adenocarcinoma (Cell Line: CAOV3)
|
[3] |
Gemcitabine + Idarubicin
|
DCELYS8
|
Gemcitabine
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[3] |
Gemcitabine + Idarubicin
|
DCFYFDC
|
Gemcitabine
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
Gemcitabine + Idarubicin
|
DC54VPW
|
Gemcitabine
|
Amelanotic melanoma (Cell Line: A2058)
|
[3] |
Gemcitabine + Idarubicin
|
DC0TRQQ
|
Gemcitabine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
Gemcitabine + Idarubicin
|
DCEQBXF
|
Gemcitabine
|
Mesothelioma (Cell Line: MSTO)
|
[3] |
Gemcitabine + Idarubicin
|
DCB2M9U
|
Gemcitabine
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[3] |
Gemfibrozil + Idarubicin
|
DCONUPQ
|
Gemfibrozil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Genistein + Idarubicin
|
DCZNT0J
|
Genistein
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Genz-668764 + Idarubicin
|
DCLQAM5
|
Genz-668764
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GINKGOLIDE A + Idarubicin
|
DC4GJJE
|
GINKGOLIDE A
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ginsenoside Rb1 + Idarubicin
|
DCRDDPW
|
Ginsenoside Rb1
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Glimepiride + Idarubicin
|
DCLJUT8
|
Glimepiride
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GNF-PF-5411 + Idarubicin
|
DC0MHFX
|
GNF-PF-5411
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GS-9005 + Idarubicin
|
DCMU2XJ
|
GS-9005
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GSK2194069 + Idarubicin
|
DCKO6SN
|
GSK2194069
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GSK256066 + Idarubicin
|
DC6AJZ4
|
GSK256066
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GSK2636771 + Idarubicin
|
DCW8A6E
|
GSK2636771
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GSK2981278 + Idarubicin
|
DCYMBV1
|
GSK2981278
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GSK525762 + Idarubicin
|
DC658LJ
|
GSK525762
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GTx-024 + Idarubicin
|
DCAS6BE
|
GTx-024
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GW1929 + Idarubicin
|
DC560YU
|
GW1929
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
GYKI-52466 + Idarubicin
|
DC1AHAN
|
GYKI-52466
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Haloperidol + Idarubicin
|
DCN2J0H
|
Haloperidol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
HESPERADIN + Idarubicin
|
DCTXS32
|
HESPERADIN
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Hydroxyflutamide + Idarubicin
|
DCY42UE
|
Hydroxyflutamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Hyodeoxycholic acid + Idarubicin
|
DC50A4Y
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Ibrutinib + Idarubicin
|
DCEOQ9S
|
Ibrutinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Idarubicin + Sertraline
|
DCGSSUX
|
Sertraline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Pentostatin
|
DCGBYXS
|
Pentostatin
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
Idarubicin + Pentostatin
|
DCBEDO3
|
Pentostatin
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
Idarubicin + Mebutamate
|
DCG92RD
|
Mebutamate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Fulvestrant
|
DCNXINP
|
Fulvestrant
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
Idarubicin + Gefitinib
|
DCCW12N
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Dantrolene
|
DC2C2QK
|
Dantrolene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Diethylcarbamazine
|
DCS6DPZ
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + PD-0325901
|
DCK3QO8
|
PD-0325901
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Citalopram
|
DCK6FH3
|
Citalopram
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Ixabepilone
|
DCZCV6I
|
Ixabepilone
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
Idarubicin + Lapatinib
|
DCKWOYB
|
Lapatinib
|
Glioma (Cell Line: SF-268)
|
[3] |
Idarubicin + Terazosin
|
DCLHK45
|
Terazosin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + MK-1775
|
DCNCQMG
|
MK-1775
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Cyclophosphamide
|
DCBRGVD
|
Cyclophosphamide
|
Glioma (Cell Line: SF-539)
|
[3] |
Idarubicin + Isoniazid
|
DCIA19K
|
Isoniazid
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Idarubicin + Isoniazid
|
DCO2NE7
|
Isoniazid
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
Idarubicin + Isoniazid
|
DCJ1V8M
|
Isoniazid
|
Glioma (Cell Line: SF-539)
|
[3] |
Idarubicin + Repaglinide
|
DCJVMU8
|
Repaglinide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + RTB101
|
DCDX0LD
|
RTB101
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + SCH-900776
|
DC3PZDU
|
SCH-900776
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Plicamycin
|
DCGBX8N
|
Plicamycin
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
Idarubicin + Plicamycin
|
DCHVWBD
|
Plicamycin
|
Glioma (Cell Line: SF-268)
|
[3] |
Idarubicin + Plicamycin
|
DCKKCQL
|
Plicamycin
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
Idarubicin + Triapine
|
DCE2SV3
|
Triapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Triapine
|
DCDBFRW
|
Triapine
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
Idarubicin + Triapine
|
DCT837I
|
Triapine
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
Idarubicin + Triapine
|
DC7VH8E
|
Triapine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
Idarubicin + Everolimus
|
DCOZ33N
|
Everolimus
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + 10-hydroxycamptothecin
|
DCEIS06
|
10-hydroxycamptothecin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Idarubicin + Topetecan
|
DCKCG63
|
Topetecan
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Idarubicin + Buspirone
|
DCABQHO
|
Buspirone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Amodiaquine
|
DCM6SX8
|
Amodiaquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Erlotinib
|
DCYQQBE
|
Erlotinib
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Ifosfamide
|
DCGXA64
|
Ifosfamide
|
Astrocytoma (Cell Line: U251)
|
[3] |
Idarubicin + Ifosfamide
|
DCJAKTX
|
Ifosfamide
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
Idarubicin + Ursodeoxycholic acid
|
DCWOVCF
|
Ursodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Cinacalcet
|
DC1GLME
|
Cinacalcet
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Raloxifene
|
DCND3KG
|
Raloxifene
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
Idarubicin + Phenprocoumon
|
DCYZ8QQ
|
Phenprocoumon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Galantamine
|
DCLUJ1I
|
Galantamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Daidzin
|
DCQTUF9
|
Daidzin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Bendamustine hydrochloride
|
DC9Y11G
|
Bendamustine hydrochloride
|
Glioma (Cell Line: SF-539)
|
[3] |
Idarubicin + Fluspirilene
|
DCWO03R
|
Fluspirilene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Armodafinil
|
DCIOXQ9
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Ciprofibrate
|
DC9R5FS
|
Ciprofibrate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Nizatidine
|
DC6GQV9
|
Nizatidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Sirolimus
|
DCQ095Z
|
Sirolimus
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
Idarubicin + Sirolimus
|
DCG0JWO
|
Sirolimus
|
Glioma (Cell Line: SF-539)
|
[3] |
Idarubicin + Mitomycin
|
DCXXANH
|
Mitomycin
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[3] |
Idarubicin + Mitomycin
|
DCXQ3WG
|
Mitomycin
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
Idarubicin + Naringenin
|
DCT05ZM
|
Naringenin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Clopidogrel
|
DCLRKVU
|
Clopidogrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Diphenidol
|
DC4E225
|
Diphenidol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Pentamidine
|
DC974PF
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Altretamine
|
DCQA354
|
Altretamine
|
Glioma (Cell Line: SF-539)
|
[3] |
Idarubicin + Altretamine
|
DC704PO
|
Altretamine
|
Renal cell carcinoma (Cell Line: UO-31)
|
[3] |
Idarubicin + TEM
|
DCU3F4J
|
TEM
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
Idarubicin + TEM
|
DC8OU7E
|
TEM
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
Idarubicin + Allopurinol
|
DC02AK8
|
Allopurinol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + MK-4827
|
DCC2OUV
|
MK-4827
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Idarubicin
|
DCZIMZX
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Idarubicin + Methocarbamol
|
DCDX0GB
|
Methocarbamol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Imatinib
|
DCWJW9P
|
Imatinib
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
Idarubicin + Bortezomib
|
DCH90BO
|
Bortezomib
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Mesalazine
|
DCOOR22
|
Mesalazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + GSK525762
|
DCSZ8T3
|
GSK525762
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Olanzapine
|
DCC5WVO
|
Olanzapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Trimethobenzamide
|
DC5EXHI
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Maprotiline
|
DCZEW61
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Eptifibatide
|
DCBQ8FP
|
Eptifibatide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Acetohexamide
|
DCV0KD2
|
Acetohexamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Acarbose
|
DCUZLQS
|
Acarbose
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Sorafenib
|
DCP0UML
|
Sorafenib
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
Idarubicin + Sorafenib
|
DCDDDPJ
|
Sorafenib
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Idarubicin + Quinine
|
DCPXE67
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Pomalidomide
|
DC3SRBJ
|
Pomalidomide
|
Astrocytoma (Cell Line: U251)
|
[3] |
Idarubicin + Pomalidomide
|
DCZNZ2U
|
Pomalidomide
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
Idarubicin + Pomalidomide
|
DC6O30T
|
Pomalidomide
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
Idarubicin + Vinflunine
|
DCM0FX8
|
Vinflunine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
Idarubicin + Vinflunine
|
DCN316N
|
Vinflunine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
Idarubicin + Vinflunine
|
DCCGHVM
|
Vinflunine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
Idarubicin + Vinflunine
|
DCTSK22
|
Vinflunine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
Idarubicin + Spironolactone
|
DCIEEOX
|
Spironolactone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Mycophenolic acid
|
DCL1E57
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Taxol
|
DCTHSO7
|
Taxol
|
Glioma (Cell Line: SF-295)
|
[3] |
Idarubicin + Doxorubicin
|
DCE15PL
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Zileuton
|
DCQ5AU8
|
Zileuton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Aminolevulinic Acid Hydrochloride
|
DCDPUAR
|
Aminolevulinic Acid Hydrochloride
|
Glioma (Cell Line: SF-539)
|
[3] |
Idarubicin + Cerivastatin
|
DCCLUFP
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Raltegravir
|
DC6Q1TC
|
Raltegravir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Dasatinib
|
DCM41TX
|
Dasatinib
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[3] |
Idarubicin + Dasatinib
|
DCK70Y3
|
Dasatinib
|
Adenocarcinoma (Cell Line: SW-620)
|
[3] |
Idarubicin + Dasatinib
|
DCGPYKQ
|
Dasatinib
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
Idarubicin + Tetracycline
|
DCUB63Y
|
Tetracycline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Idarubicin + Pentostatin
|
DCMCNBN
|
Pentostatin
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
Idarubicin + Fulvestrant
|
DC7IPU4
|
Fulvestrant
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Idarubicin + PD-0325901
|
DC846KO
|
PD-0325901
|
Breast carcinoma (Cell Line: KPL1)
|
[4] |
Idarubicin + PD-0325901
|
DCYIHJS
|
PD-0325901
|
Breast carcinoma (Cell Line: OCUBM)
|
[4] |
Idarubicin + PD-0325901
|
DCGW9EH
|
PD-0325901
|
Carcinoma (Cell Line: OV90)
|
[4] |
Idarubicin + PD-0325901
|
DC02R95
|
PD-0325901
|
Carcinoma (Cell Line: EFM192B)
|
[4] |
Idarubicin + PD-0325901
|
DCMZH25
|
PD-0325901
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + PD-0325901
|
DCC2Y0H
|
PD-0325901
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Idarubicin + Lapatinib
|
DCX5ELE
|
Lapatinib
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + MK-1775
|
DCNBZAE
|
MK-1775
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289)
|
[4] |
Idarubicin + MK-1775
|
DCESJGB
|
MK-1775
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)
|
[4] |
Idarubicin + MK-1775
|
DCQXID2
|
MK-1775
|
Breast carcinoma (Cell Line: OCUBM)
|
[4] |
Idarubicin + MK-1775
|
DC1U2QD
|
MK-1775
|
Carcinoma (Cell Line: OV90)
|
[4] |
Idarubicin + MK-1775
|
DCEK5FD
|
MK-1775
|
Carcinoma (Cell Line: EFM192B)
|
[4] |
Idarubicin + MK-1775
|
DCPQH4N
|
MK-1775
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + MK-1775
|
DC1Z1AK
|
MK-1775
|
Colon adenocarcinoma (Cell Line: LOVO)
|
[4] |
Idarubicin + MK-1775
|
DCVDCXG
|
MK-1775
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Idarubicin + Cyclophosphamide
|
DCAWVDV
|
Cyclophosphamide
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
Idarubicin + Isoniazid
|
DCBWOB3
|
Isoniazid
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Idarubicin + SCH-900776
|
DCVVTQA
|
SCH-900776
|
Carcinoma (Cell Line: OV90)
|
[4] |
Idarubicin + SCH-900776
|
DCPK21J
|
SCH-900776
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Idarubicin + Triapine
|
DC08HWP
|
Triapine
|
Carcinoma (Cell Line: MCF7)
|
[4] |
Idarubicin + Triapine
|
DCADJ4N
|
Triapine
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Idarubicin + SNX-2112
|
DCCW4HM
|
SNX-2112
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289)
|
[4] |
Idarubicin + SNX-2112
|
DC9AU8K
|
SNX-2112
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + Ifosfamide
|
DCT5CKV
|
Ifosfamide
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
Idarubicin + MK-5108
|
DC5COV0
|
MK-5108
|
Colon carcinoma (Cell Line: RKO)
|
[4] |
Idarubicin + MK-5108
|
DC46JGB
|
MK-5108
|
Rectal adenocarcinoma (Cell Line: SW837)
|
[4] |
Idarubicin + Ridaforolimus
|
DC8H1YH
|
Ridaforolimus
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)
|
[4] |
Idarubicin + MK-4827
|
DC5B4AY
|
MK-4827
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + MK-4827
|
DCSIZOX
|
MK-4827
|
Colon carcinoma (Cell Line: RKO)
|
[4] |
Idarubicin + Imatinib
|
DCZFDFX
|
Imatinib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Idarubicin + Bortezomib
|
DCW5PVP
|
Bortezomib
|
Carcinoma (Cell Line: OV90)
|
[4] |
Idarubicin + Bortezomib
|
DCEPO2U
|
Bortezomib
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + GSK525762
|
DC7VQ3D
|
GSK525762
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)
|
[4] |
Idarubicin + GSK525762
|
DCCPGMW
|
GSK525762
|
Breast carcinoma (Cell Line: ZR751)
|
[4] |
Idarubicin + GSK525762
|
DCIIOPZ
|
GSK525762
|
Breast carcinoma (Cell Line: OCUBM)
|
[4] |
Idarubicin + GSK525762
|
DCCRAJG
|
GSK525762
|
Carcinoma (Cell Line: OV90)
|
[4] |
Idarubicin + GSK525762
|
DCNW3UV
|
GSK525762
|
Carcinoma (Cell Line: EFM192B)
|
[4] |
Idarubicin + GSK525762
|
DCUTV2S
|
GSK525762
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Idarubicin + GSK525762
|
DCS0JZU
|
GSK525762
|
Colon adenocarcinoma (Cell Line: LOVO)
|
[4] |
Idarubicin + GSK525762
|
DCH43ZO
|
GSK525762
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Idarubicin + GSK525762
|
DCUXRBQ
|
GSK525762
|
Rectal adenocarcinoma (Cell Line: SW837)
|
[4] |
Idarubicin + Sorafenib
|
DCBKOJT
|
Sorafenib
|
Breast carcinoma (Cell Line: ZR751)
|
[4] |
Idarubicin + Vinflunine
|
DCCGCBM
|
Vinflunine
|
Carcinoma (Cell Line: MCF7)
|
[4] |
Idarubicin + Vinflunine
|
DCFB65P
|
Vinflunine
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Idarubicin + Vinflunine
|
DCFPNKR
|
Vinflunine
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Idarubicin + PMID28870136-Compound-43
|
DCHEUVD
|
PMID28870136-Compound-43
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Idarubicin + FORMESTANE
|
DCGV3ON
|
FORMESTANE
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
Idarubicin + Pentostatin
|
DCOIT7G
|
Pentostatin
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + Pentostatin
|
DC25U8F
|
Pentostatin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + Fulvestrant
|
DCZAIIA
|
Fulvestrant
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + PD-0325901
|
DCIWIFF
|
PD-0325901
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + PD-0325901
|
DCRFJ4E
|
PD-0325901
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + PD-0325901
|
DC5KHUQ
|
PD-0325901
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + PD-0325901
|
DC36ADM
|
PD-0325901
|
Adenocarcinoma (Cell Line: NCIH520)
|
[5] |
Idarubicin + PD-0325901
|
DCXGARB
|
PD-0325901
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + PD-0325901
|
DC036XS
|
PD-0325901
|
Adenocarcinoma (Cell Line: DLD1)
|
[5] |
Idarubicin + PD-0325901
|
DCT3VG4
|
PD-0325901
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + PD-0325901
|
DCK7L3P
|
PD-0325901
|
Germ cell tumour (Cell Line: PA1)
|
[5] |
Idarubicin + PD-0325901
|
DC5MMFN
|
PD-0325901
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + PD-0325901
|
DC4YD0T
|
PD-0325901
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + PD-0325901
|
DCS2G1Q
|
PD-0325901
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + PD-0325901
|
DC0SIR0
|
PD-0325901
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + PD-0325901
|
DCH8R8G
|
PD-0325901
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + PD-0325901
|
DC52CUG
|
PD-0325901
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Hepzato
|
DCD52ZM
|
Hepzato
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Idarubicin + Dactinomycin
|
DCQYMZU
|
Dactinomycin
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + Dactinomycin
|
DCV91SU
|
Dactinomycin
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
Idarubicin + Lapatinib
|
DCRP3PA
|
Lapatinib
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + Lapatinib
|
DCD1SOT
|
Lapatinib
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + Lapatinib
|
DCDNQBV
|
Lapatinib
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + Lapatinib
|
DC00HWL
|
Lapatinib
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + Lapatinib
|
DCC4E8I
|
Lapatinib
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Lapatinib
|
DCLFQLH
|
Lapatinib
|
Germ cell tumour (Cell Line: PA1)
|
[5] |
Idarubicin + Lapatinib
|
DCFXD31
|
Lapatinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + Lapatinib
|
DC9A9VD
|
Lapatinib
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + Lapatinib
|
DCG9MF0
|
Lapatinib
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + Lapatinib
|
DCKYM3W
|
Lapatinib
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + Lapatinib
|
DCDFID5
|
Lapatinib
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + Lapatinib
|
DCZZXSM
|
Lapatinib
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + MK-1775
|
DCX6RFQ
|
MK-1775
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + MK-1775
|
DC28HEO
|
MK-1775
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + MK-1775
|
DCTM16L
|
MK-1775
|
Adenocarcinoma (Cell Line: NCIH1650)
|
[5] |
Idarubicin + MK-1775
|
DCUD797
|
MK-1775
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + MK-1775
|
DCJGDUJ
|
MK-1775
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + MK-1775
|
DCJH09S
|
MK-1775
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + MK-1775
|
DCTU7Z1
|
MK-1775
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + MK-1775
|
DCFWILX
|
MK-1775
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + MK-1775
|
DCWEZ0T
|
MK-1775
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + MK-1775
|
DCBGW24
|
MK-1775
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + MK-1775
|
DCHA3Z6
|
MK-1775
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + MK-1775
|
DC4PRQ1
|
MK-1775
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + MK-1775
|
DCT4OGF
|
MK-1775
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + MK-1775
|
DCPVB08
|
MK-1775
|
Non small cell carcinoma (Cell Line: SKMES1)
|
[5] |
Idarubicin + MK-1775
|
DCWYB3D
|
MK-1775
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + MK-1775
|
DCK1LH4
|
MK-1775
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
Idarubicin + Cyclophosphamide
|
DCRKTG1
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + Cyclophosphamide
|
DCIFA5M
|
Cyclophosphamide
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[5] |
Idarubicin + Isoniazid
|
DCNPKG5
|
Isoniazid
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
Idarubicin + Isoniazid
|
DC5SFRT
|
Isoniazid
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[5] |
Idarubicin + Arsenic trioxide
|
DCDAF4M
|
Arsenic trioxide
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + Arsenic trioxide
|
DC2QYCU
|
Arsenic trioxide
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + RTB101
|
DCFYMW7
|
RTB101
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + RTB101
|
DCJCJWE
|
RTB101
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + RTB101
|
DCF1ZZH
|
RTB101
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + RTB101
|
DC206QY
|
RTB101
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + RTB101
|
DCA3W2Z
|
RTB101
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + RTB101
|
DCN1NCB
|
RTB101
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + RTB101
|
DCKPVQ7
|
RTB101
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + RTB101
|
DCPUDH1
|
RTB101
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + RTB101
|
DC6PVEO
|
RTB101
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + RTB101
|
DCZOMB8
|
RTB101
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + RTB101
|
DCDHQYZ
|
RTB101
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + SCH-900776
|
DC79XNT
|
SCH-900776
|
Adenocarcinoma (Cell Line: CAOV3)
|
[5] |
Idarubicin + SCH-900776
|
DCZ5OCC
|
SCH-900776
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + SCH-900776
|
DCZLE36
|
SCH-900776
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + SCH-900776
|
DCRV2EX
|
SCH-900776
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + SCH-900776
|
DCF3RFV
|
SCH-900776
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + SCH-900776
|
DCOX8DV
|
SCH-900776
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + SCH-900776
|
DCL7PM8
|
SCH-900776
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + SCH-900776
|
DCW1PG6
|
SCH-900776
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + SCH-900776
|
DCRNMQK
|
SCH-900776
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + SCH-900776
|
DCEH6JU
|
SCH-900776
|
Malignant melanoma (Cell Line: SKMEL30)
|
[5] |
Idarubicin + SCH-900776
|
DCR9N5N
|
SCH-900776
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + SCH-900776
|
DC3S21B
|
SCH-900776
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + SCH-900776
|
DCHAX3W
|
SCH-900776
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Plicamycin
|
DCINYI6
|
Plicamycin
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Idarubicin + Nilotinib
|
DCW1QWP
|
Nilotinib
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Idarubicin + Nilotinib
|
DCDY5E9
|
Nilotinib
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
Idarubicin + Nilotinib
|
DCQ2IOS
|
Nilotinib
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[5] |
Idarubicin + Triapine
|
DCAZSAH
|
Triapine
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + Triapine
|
DC8NWEW
|
Triapine
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + Triapine
|
DCR4909
|
Triapine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[5] |
Idarubicin + 10-hydroxycamptothecin
|
DCTDZRI
|
10-hydroxycamptothecin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + 10-hydroxycamptothecin
|
DCJYYQA
|
10-hydroxycamptothecin
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + 10-hydroxycamptothecin
|
DCPSQTW
|
10-hydroxycamptothecin
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + 10-hydroxycamptothecin
|
DCTSC9P
|
10-hydroxycamptothecin
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + 10-hydroxycamptothecin
|
DC3FGF0
|
10-hydroxycamptothecin
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Pralatrexate
|
DCVA6GE
|
Pralatrexate
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
Idarubicin + Pralatrexate
|
DC9TWWT
|
Pralatrexate
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + SNX-2112
|
DCCIJ7I
|
SNX-2112
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + SNX-2112
|
DCREE7M
|
SNX-2112
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + SNX-2112
|
DCWPKY9
|
SNX-2112
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + SNX-2112
|
DC25FOK
|
SNX-2112
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + SNX-2112
|
DCUGE12
|
SNX-2112
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + SNX-2112
|
DCQF5K6
|
SNX-2112
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Terameprocol
|
DCXWIVI
|
Terameprocol
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + Terameprocol
|
DCPGEBZ
|
Terameprocol
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[5] |
Idarubicin + Terameprocol
|
DC1ADAR
|
Terameprocol
|
Prostate carcinoma (Cell Line: PC-3)
|
[5] |
Idarubicin + SCH 727965
|
DCOT79P
|
SCH 727965
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + Erlotinib
|
DCQA8PI
|
Erlotinib
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + Erlotinib
|
DCJ5U1J
|
Erlotinib
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + Erlotinib
|
DCS3UVL
|
Erlotinib
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + Erlotinib
|
DCPE80I
|
Erlotinib
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + Erlotinib
|
DC2OJIG
|
Erlotinib
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Erlotinib
|
DCYJ7YF
|
Erlotinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + Erlotinib
|
DCHNNUF
|
Erlotinib
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + Erlotinib
|
DCW4WK8
|
Erlotinib
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + Erlotinib
|
DCWAD5N
|
Erlotinib
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + Erlotinib
|
DCI8GK2
|
Erlotinib
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + Erlotinib
|
DCPF2BZ
|
Erlotinib
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Ifosfamide
|
DCYRPNB
|
Ifosfamide
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
Idarubicin + Ifosfamide
|
DCQ5Z2Q
|
Ifosfamide
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
Idarubicin + Ifosfamide
|
DCSLO6B
|
Ifosfamide
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[5] |
Idarubicin + Ifosfamide
|
DC6D8CO
|
Ifosfamide
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + Ifosfamide
|
DCDGOLB
|
Ifosfamide
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[5] |
Idarubicin + Docetaxel
|
DCAL0KN
|
Docetaxel
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + Raloxifene
|
DCATEPG
|
Raloxifene
|
Amelanotic melanoma (Cell Line: M14)
|
[5] |
Idarubicin + Raloxifene
|
DCRFYVV
|
Raloxifene
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[5] |
Idarubicin + Raloxifene
|
DCDVE4U
|
Raloxifene
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + MK-5108
|
DCFX184
|
MK-5108
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + MK-5108
|
DC70V0L
|
MK-5108
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + MK-5108
|
DC5J8GB
|
MK-5108
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + MK-5108
|
DC5IEVE
|
MK-5108
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + MK-5108
|
DCNGA17
|
MK-5108
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
Idarubicin + Mitomycin
|
DCQP2X6
|
Mitomycin
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
Idarubicin + Mitomycin
|
DCDA8HP
|
Mitomycin
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
Idarubicin + Altretamine
|
DCWU8UD
|
Altretamine
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + Altretamine
|
DCQKPE9
|
Altretamine
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[5] |
Idarubicin + Altretamine
|
DCFNPUY
|
Altretamine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
Idarubicin + Altretamine
|
DCOWXNO
|
Altretamine
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[5] |
Idarubicin + Ridaforolimus
|
DC5RM9J
|
Ridaforolimus
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + Ridaforolimus
|
DCSWFFQ
|
Ridaforolimus
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + Ridaforolimus
|
DCFCXPK
|
Ridaforolimus
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Ridaforolimus
|
DCZ8RF3
|
Ridaforolimus
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + Ridaforolimus
|
DC09LTY
|
Ridaforolimus
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + TEM
|
DCCNJJX
|
TEM
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
Idarubicin + TEM
|
DCG6FPC
|
TEM
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[5] |
Idarubicin + TEM
|
DCKMWFC
|
TEM
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + MK-4827
|
DCMQESX
|
MK-4827
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + MK-4827
|
DCHWG2F
|
MK-4827
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + MK-4827
|
DCJFV7N
|
MK-4827
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + MK-4827
|
DCETASI
|
MK-4827
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + MK-4827
|
DCVCNGI
|
MK-4827
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + MK-4827
|
DCXX7J4
|
MK-4827
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + MK-4827
|
DC27IAU
|
MK-4827
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + MK-4827
|
DCTGFDP
|
MK-4827
|
Germ cell tumour (Cell Line: PA1)
|
[5] |
Idarubicin + MK-4827
|
DCSSAKR
|
MK-4827
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + MK-4827
|
DCT6D17
|
MK-4827
|
Malignant melanoma (Cell Line: HT144)
|
[5] |
Idarubicin + MK-4827
|
DCXL7YD
|
MK-4827
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + MK-4827
|
DCRACVR
|
MK-4827
|
Malignant melanoma (Cell Line: SKMEL30)
|
[5] |
Idarubicin + MK-4827
|
DCDXBEC
|
MK-4827
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + MK-4827
|
DC1SS8O
|
MK-4827
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + MK-4827
|
DC6CUKI
|
MK-4827
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + MK-4827
|
DC4SIYG
|
MK-4827
|
Non small cell carcinoma (Cell Line: SKMES1)
|
[5] |
Idarubicin + MK-4827
|
DC9TFEC
|
MK-4827
|
Prostate carcinoma (Cell Line: VCAP)
|
[5] |
Idarubicin + Imatinib
|
DCN7TMH
|
Imatinib
|
Melanoma (Cell Line: UACC-257)
|
[5] |
Idarubicin + Imatinib
|
DCP0317
|
Imatinib
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
Idarubicin + Lomustine
|
DC0UPSE
|
Lomustine
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + Lomustine
|
DCQKNQ3
|
Lomustine
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + Lomustine
|
DCE08FW
|
Lomustine
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + Lomustine
|
DCG714U
|
Lomustine
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Bortezomib
|
DCDVCWP
|
Bortezomib
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + Bortezomib
|
DCZ9CR9
|
Bortezomib
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Bortezomib
|
DC4N1Y3
|
Bortezomib
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + GSK525762
|
DCYVYLR
|
GSK525762
|
Adenocarcinoma (Cell Line: CAOV3)
|
[5] |
Idarubicin + GSK525762
|
DCYG5V5
|
GSK525762
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + GSK525762
|
DCA5EWL
|
GSK525762
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + GSK525762
|
DCOMSYM
|
GSK525762
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + GSK525762
|
DCQNS7Y
|
GSK525762
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Idarubicin + GSK525762
|
DCH09WN
|
GSK525762
|
Adenocarcinoma (Cell Line: NCIH520)
|
[5] |
Idarubicin + GSK525762
|
DCCZS5X
|
GSK525762
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + GSK525762
|
DCGINVR
|
GSK525762
|
Adenocarcinoma (Cell Line: DLD1)
|
[5] |
Idarubicin + GSK525762
|
DCYK55D
|
GSK525762
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + GSK525762
|
DCERMII
|
GSK525762
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Idarubicin + GSK525762
|
DCW8JLE
|
GSK525762
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + GSK525762
|
DC9LAL3
|
GSK525762
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + GSK525762
|
DCNV777
|
GSK525762
|
Germ cell tumour (Cell Line: PA1)
|
[5] |
Idarubicin + GSK525762
|
DCGGFG6
|
GSK525762
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + GSK525762
|
DCQR30U
|
GSK525762
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + GSK525762
|
DCWYY4R
|
GSK525762
|
Malignant melanoma (Cell Line: HT144)
|
[5] |
Idarubicin + GSK525762
|
DCCO826
|
GSK525762
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + GSK525762
|
DCNY6TU
|
GSK525762
|
Malignant melanoma (Cell Line: SKMEL30)
|
[5] |
Idarubicin + GSK525762
|
DCTA3XW
|
GSK525762
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + GSK525762
|
DCI2G2Z
|
GSK525762
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + GSK525762
|
DCZG9XK
|
GSK525762
|
Non small cell carcinoma (Cell Line: SKMES1)
|
[5] |
Idarubicin + GSK525762
|
DCMQI83
|
GSK525762
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + GSK525762
|
DC7RZNG
|
GSK525762
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
Idarubicin + GSK525762
|
DCLLYNA
|
GSK525762
|
Prostate carcinoma (Cell Line: LNCAP)
|
[5] |
Idarubicin + GSK525762
|
DCKATEH
|
GSK525762
|
Prostate carcinoma (Cell Line: VCAP)
|
[5] |
Idarubicin + Cisplatin
|
DCJL8PZ
|
Cisplatin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + Sorafenib
|
DC88A1D
|
Sorafenib
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
Idarubicin + Sorafenib
|
DCEQ2A0
|
Sorafenib
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + Sorafenib
|
DC04R1S
|
Sorafenib
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + Sorafenib
|
DCUS4CO
|
Sorafenib
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Sorafenib
|
DCF3IOF
|
Sorafenib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
Idarubicin + Sorafenib
|
DCW8ZRK
|
Sorafenib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + Sorafenib
|
DCE72CT
|
Sorafenib
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
Idarubicin + Sorafenib
|
DC6F0PY
|
Sorafenib
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + Sorafenib
|
DC4I4UN
|
Sorafenib
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + Sorafenib
|
DCSVNF5
|
Sorafenib
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + ER819762
|
DCPY550
|
ER819762
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
Idarubicin + ER819762
|
DCEUCPD
|
ER819762
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
Idarubicin + MK-2206
|
DCXWCT1
|
MK-2206
|
Adenocarcinoma (Cell Line: CAOV3)
|
[5] |
Idarubicin + MK-2206
|
DCWGALF
|
MK-2206
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + MK-2206
|
DCZYOC7
|
MK-2206
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + MK-2206
|
DCWLUT3
|
MK-2206
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Idarubicin + MK-2206
|
DCZMHKX
|
MK-2206
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Idarubicin + MK-2206
|
DCH775J
|
MK-2206
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + MK-2206
|
DC3AL14
|
MK-2206
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + MK-2206
|
DCKC8RX
|
MK-2206
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + MK-2206
|
DCC6N72
|
MK-2206
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + MK-2206
|
DCWX89S
|
MK-2206
|
Malignant melanoma (Cell Line: SKMEL30)
|
[5] |
Idarubicin + MK-2206
|
DCZF6RN
|
MK-2206
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + MK-2206
|
DCVLWWC
|
MK-2206
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + MK-2206
|
DCEHZAF
|
MK-2206
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Pomalidomide
|
DCOGQ7O
|
Pomalidomide
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[5] |
Idarubicin + Pomalidomide
|
DCII0GJ
|
Pomalidomide
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Idarubicin + Pomalidomide
|
DC6KVPO
|
Pomalidomide
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
Idarubicin + Pomalidomide
|
DC821O5
|
Pomalidomide
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[5] |
Idarubicin + Vinflunine
|
DCISIAG
|
Vinflunine
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
Idarubicin + Vinflunine
|
DCEFXO1
|
Vinflunine
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
Idarubicin + Vinflunine
|
DC62DA6
|
Vinflunine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[5] |
Idarubicin + Vinflunine
|
DCP1P3N
|
Vinflunine
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
Idarubicin + Vinflunine
|
DCNJV4A
|
Vinflunine
|
Prostate carcinoma (Cell Line: PC-3)
|
[5] |
Idarubicin + Mercaptopurine
|
DC42BZO
|
Mercaptopurine
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
Idarubicin + Vorinostat
|
DCLJMAS
|
Vorinostat
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Idarubicin + Vorinostat
|
DC8BHW5
|
Vorinostat
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Vorinostat
|
DCVIIHX
|
Vorinostat
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + Vorinostat
|
DCABAXC
|
Vorinostat
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Idarubicin + Vorinostat
|
DC870WL
|
Vorinostat
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + Vorinostat
|
DC3FNKP
|
Vorinostat
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
Idarubicin + Vorinostat
|
DCEFFRL
|
Vorinostat
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + Vorinostat
|
DCIGQN8
|
Vorinostat
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idarubicin + Busulfan
|
DC06YGM
|
Busulfan
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
Idarubicin + Busulfan
|
DCJP8YU
|
Busulfan
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[5] |
Idarubicin + Dasatinib
|
DCS9P4X
|
Dasatinib
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Idarubicin + Dasatinib
|
DC59XVX
|
Dasatinib
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Idarubicin + Dasatinib
|
DCQCDK9
|
Dasatinib
|
Germ cell tumour (Cell Line: PA1)
|
[5] |
Idarubicin + Dasatinib
|
DC3PT24
|
Dasatinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Idarubicin + Dasatinib
|
DCCRZI5
|
Dasatinib
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Idarubicin + Dasatinib
|
DCCYE6G
|
Dasatinib
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Idarubicin + Dasatinib
|
DC0GWGG
|
Dasatinib
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Idelalisib + Idarubicin
|
DCP33A2
|
Idelalisib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Idoxuridine + Idarubicin
|
DC4HST5
|
Idoxuridine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
IDP-123 + Idarubicin
|
DCF1C3J
|
IDP-123
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Imatinib + Idarubicin
|
DC6CELA
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Imatinib + Idarubicin
|
DC3ASTQ
|
Imatinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Imipenem + Idarubicin
|
DCZL2D8
|
Imipenem
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Indazole derivative 5 + Idarubicin
|
DCJEF9Z
|
Indazole derivative 5
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Indazole derivative 5 + Idarubicin
|
DCDEVNM
|
Indazole derivative 5
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Indisulam + Idarubicin
|
DC6HILR
|
Indisulam
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Indomethacin + Idarubicin
|
DCTVNM7
|
Indomethacin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
INO-1001 + Idarubicin
|
DC2IZZH
|
INO-1001
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Isoniazid + Idarubicin
|
DC9272Q
|
Isoniazid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Isosorbide dinitrate + Idarubicin
|
DCBDOGB
|
Isosorbide dinitrate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
IT-141 + Idarubicin
|
DCIQZP1
|
IT-141
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Itraconazole + Idarubicin
|
DC3AO83
|
Itraconazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
JNJ-38877605 + Idarubicin
|
DCESNHS
|
JNJ-38877605
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
JNJ-42041935 + Idarubicin
|
DC5Y4YK
|
JNJ-42041935
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
JNJ-7706621 + Idarubicin
|
DC16YAD
|
JNJ-7706621
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
JNK-IN-8 + Idarubicin
|
DCKGG36
|
JNK-IN-8
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
K-134 + Idarubicin
|
DC1STNX
|
K-134
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Ketanserin + Idarubicin
|
DCF22EA
|
Ketanserin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ketoconazole + Idarubicin
|
DCPRMTT
|
Ketoconazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ketorolac + Idarubicin
|
DCRMZU8
|
Ketorolac
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Kinetin + Idarubicin
|
DCGZ73V
|
Kinetin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
KL001 + Idarubicin
|
DCTK3FP
|
KL001
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
KU-60019 + Idarubicin
|
DCVBUKV
|
KU-60019
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
KW-2449 + Idarubicin
|
DCMI4KB
|
KW-2449
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
KX-01 + Idarubicin
|
DC54TL2
|
KX-01
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
L690330 + Idarubicin
|
DCJUGHR
|
L690330
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lactulose + Idarubicin
|
DCG06ML
|
Lactulose
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lamivudine + Idarubicin
|
DCWYW12
|
Lamivudine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Leflunomide + Idarubicin
|
DCHEY5D
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Lenalidomide + Idarubicin
|
DCJSPQ4
|
Lenalidomide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
Lenalidomide + Idarubicin
|
DCR7K00
|
Lenalidomide
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Lenalidomide + Idarubicin
|
DCOHY99
|
Lenalidomide
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
Lenalidomide + Idarubicin
|
DCVQZDY
|
Lenalidomide
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
Lenalidomide + Idarubicin
|
DCSJTMO
|
Lenalidomide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lenalidomide + Idarubicin
|
DCM5HWX
|
Lenalidomide
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Lenalidomide + Idarubicin
|
DCSTUS9
|
Lenalidomide
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
Lenalidomide + Idarubicin
|
DCA1QN2
|
Lenalidomide
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Lenalidomide + Idarubicin
|
DCSHSDR
|
Lenalidomide
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Lenalidomide + Idarubicin
|
DCHOGVO
|
Lenalidomide
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
Lenalidomide + Idarubicin
|
DCN93SY
|
Lenalidomide
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[5] |
Lenalidomide + Idarubicin
|
DCBA7MB
|
Lenalidomide
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
Letrozole + Idarubicin
|
DC6JIXU
|
Letrozole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Letrozole + Idarubicin
|
DC081KB
|
Letrozole
|
Glioma (Cell Line: SF-539)
|
[3] |
Letrozole + Idarubicin
|
DCDT96O
|
Letrozole
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
Letrozole + Idarubicin
|
DC3RO0Z
|
Letrozole
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
Letrozole + Idarubicin
|
DC9BSG5
|
Letrozole
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Levofloxacin + Idarubicin
|
DCSVAE6
|
Levofloxacin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Levosimendan + Idarubicin
|
DC8R1JG
|
Levosimendan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lexibulin + Idarubicin
|
DCL7SHQ
|
Lexibulin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
LGK974 + Idarubicin
|
DCONK4Q
|
LGK974
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
LIAROZOLE + Idarubicin
|
DCFIB9U
|
LIAROZOLE
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
LIAROZOLE + Idarubicin
|
DCCMVUS
|
LIAROZOLE
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
Lidoflazine + Idarubicin
|
DCTQPZW
|
Lidoflazine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Linagliptin + Idarubicin
|
DC7NRO6
|
Linagliptin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Linopirdine + Idarubicin
|
DC29IAD
|
Linopirdine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
LM-94 + Idarubicin
|
DCFCZQI
|
LM-94
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lomeguatrib + Idarubicin
|
DCV5CSB
|
Lomeguatrib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lomustine + Idarubicin
|
DCHSVL1
|
Lomustine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Loperamide + Idarubicin
|
DCRKQQH
|
Loperamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Lopinavir + Idarubicin
|
DCVEC89
|
Lopinavir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lornoxicam + Idarubicin
|
DC6GCJA
|
Lornoxicam
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lovastatin + Idarubicin
|
DCRHWEN
|
Lovastatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lubiprostone + Idarubicin
|
DCBUW8R
|
Lubiprostone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Lumefantrine + Idarubicin
|
DCBHVI6
|
Lumefantrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
LY03004 + Idarubicin
|
DC9PF41
|
LY03004
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
LY335979 + Idarubicin
|
DCEAQ45
|
LY335979
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Maprotiline + Idarubicin
|
DCS1OMC
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Maraviroc + Idarubicin
|
DCWPCHK
|
Maraviroc
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
MCI-186 + Idarubicin
|
DC113E6
|
MCI-186
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Mecamylamine + Idarubicin
|
DCQW3SP
|
Mecamylamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Mechlorethamine + Idarubicin
|
DC74XL2
|
Mechlorethamine
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
Mechlorethamine + Idarubicin
|
DC0GY1C
|
Mechlorethamine
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[5] |
Mechlorethamine + Idarubicin
|
DC8PCAP
|
Mechlorethamine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[5] |
Mechlorethamine + Idarubicin
|
DCNNYGX
|
Mechlorethamine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
Mechlorethamine + Idarubicin
|
DCI1QTA
|
Mechlorethamine
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
Mechlorethamine + Idarubicin
|
DCMCYZC
|
Mechlorethamine
|
Melanoma (Cell Line: UACC-257)
|
[5] |
Mefloquine + Idarubicin
|
DCI2AG9
|
Mefloquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Megesterol acetate + Idarubicin
|
DCTSBPP
|
Megesterol acetate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Melatonin + Idarubicin
|
DCZXQUU
|
Melatonin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Meloxicam + Idarubicin
|
DC2T42X
|
Meloxicam
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Melphalan + Idarubicin
|
DCXY3MW
|
Melphalan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Menadione + Idarubicin
|
DCNL2VW
|
Menadione
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Mepacrine + Idarubicin
|
DCT6TXN
|
Mepacrine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Mesna + Idarubicin
|
DCM3D1D
|
Mesna
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Mestranol + Idarubicin
|
DCR0C3E
|
Mestranol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Metaxalone + Idarubicin
|
DCKC1PH
|
Metaxalone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Metformin + Idarubicin
|
DCC1ZVH
|
Metformin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
Metformin + Idarubicin
|
DC5XSYW
|
Metformin
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[3] |
Metformin + Idarubicin
|
DC2J9YO
|
Metformin
|
Adenocarcinoma (Cell Line: DLD1)
|
[3] |
Metformin + Idarubicin
|
DCLTB88
|
Metformin
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
Metformin + Idarubicin
|
DCWCFGH
|
Metformin
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
Metformin + Idarubicin
|
DC7KSAM
|
Metformin
|
Germ cell tumour (Cell Line: PA1)
|
[3] |
Metformin + Idarubicin
|
DCQLAMW
|
Metformin
|
Malignant melanoma (Cell Line: HT144)
|
[3] |
Metformin + Idarubicin
|
DCYI5XV
|
Metformin
|
Malignant melanoma (Cell Line: SKMEL30)
|
[3] |
Metformin + Idarubicin
|
DCJH73L
|
Metformin
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
Metformin + Idarubicin
|
DCITYQF
|
Metformin
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[3] |
Metformin + Idarubicin
|
DC2A9T6
|
Metformin
|
Prostate carcinoma (Cell Line: VCAP)
|
[3] |
Metformin + Idarubicin
|
DCASK83
|
Metformin
|
Prostate carcinoma (Cell Line: LNCAP)
|
[3] |
Metformin + Idarubicin
|
DCLODDC
|
Metformin
|
Breast carcinoma (Cell Line: KPL1)
|
[4] |
Metformin + Idarubicin
|
DC5MXH3
|
Metformin
|
Carcinoma (Cell Line: MDAMB436)
|
[4] |
Metformin + Idarubicin
|
DC3YCMC
|
Metformin
|
Colon carcinoma (Cell Line: RKO)
|
[4] |
Metformin + Idarubicin
|
DCQYMFP
|
Metformin
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
Methotrexate + Idarubicin
|
DC32ZUJ
|
Methotrexate
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
Methotrexate + Idarubicin
|
DCMLDLK
|
Methotrexate
|
Adenocarcinoma (Cell Line: NCIH520)
|
[3] |
Methotrexate + Idarubicin
|
DC61CFB
|
Methotrexate
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[3] |
Methotrexate + Idarubicin
|
DC38RMV
|
Methotrexate
|
Colon adenocarcinoma (Cell Line: LOVO)
|
[4] |
Methylene blue + Idarubicin
|
DCLLTLN
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Methylergonovine + Idarubicin
|
DCU04LX
|
Methylergonovine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
MG-132 + Idarubicin
|
DCVRUH8
|
MG-132
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
MGCD265 + Idarubicin
|
DC9EOUZ
|
MGCD265
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Miconazole + Idarubicin
|
DCFB8WP
|
Miconazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Miglustat + Idarubicin
|
DCI53LJ
|
Miglustat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Minocycline + Idarubicin
|
DCO95EJ
|
Minocycline
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Mitomycin + Idarubicin
|
DCRS0WL
|
Mitomycin
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Mitomycin + Idarubicin
|
DC7FHVJ
|
Mitomycin
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)
|
[4] |
Mitomycin + Idarubicin
|
DCKYOFW
|
Mitomycin
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Mitomycin + Idarubicin
|
DCIMCD1
|
Mitomycin
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Mitomycin + Idarubicin
|
DCHS1CN
|
Mitomycin
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Mitomycin + Idarubicin
|
DCK6OKC
|
Mitomycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Mitomycin + Idarubicin
|
DC1TXYJ
|
Mitomycin
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Mitomycin + Idarubicin
|
DCQAWG6
|
Mitomycin
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Mitomycin + Idarubicin
|
DCP4XKC
|
Mitomycin
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Mitomycin + Idarubicin
|
DCWN4I2
|
Mitomycin
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
MK-0752 + Idarubicin
|
DCQLNSB
|
MK-0752
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
MK-2461 + Idarubicin
|
DCOUAIM
|
MK-2461
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
MK-3207 + Idarubicin
|
DCRKDX7
|
MK-3207
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
MK-4827 + Idarubicin
|
DC2D9RP
|
MK-4827
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
MK-5108 + Idarubicin
|
DCZAIVY
|
MK-5108
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Monobenzone + Idarubicin
|
DCS1JBJ
|
Monobenzone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Mycophenolic acid + Idarubicin
|
DC7MW5J
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Mycophenolic acid + Idarubicin
|
DCN64GS
|
Mycophenolic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Myricetin + Idarubicin
|
DC64XYH
|
Myricetin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Naftopidil + Idarubicin
|
DC1A69K
|
Naftopidil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Naltrexone + Idarubicin
|
DC8DF9Y
|
Naltrexone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Natamycin + Idarubicin
|
DCY9C0F
|
Natamycin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nepafenac + Idarubicin
|
DC2ZN3C
|
Nepafenac
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nevirapine + Idarubicin
|
DCOQ1FN
|
Nevirapine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Niclosamide + Idarubicin
|
DCIUQLC
|
Niclosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Nicorandil + Idarubicin
|
DC8QXDU
|
Nicorandil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nicotinamide + Idarubicin
|
DCBJR99
|
Nicotinamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Niflumic acid + Idarubicin
|
DC5G7JJ
|
Niflumic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Niguldipine + Idarubicin
|
DCAI5LH
|
Niguldipine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nilotinib + Idarubicin
|
DCUO750
|
Nilotinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nitazoxanide + Idarubicin
|
DCMA5FD
|
Nitazoxanide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nitisinone + Idarubicin
|
DCOAZJQ
|
Nitisinone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nitrosoglutathione + Idarubicin
|
DCXAKCO
|
Nitrosoglutathione
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Novobiocin + Idarubicin
|
DCOE9QH
|
Novobiocin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
NUTLIN-3 + Idarubicin
|
DC3321T
|
NUTLIN-3
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Nystatin + Idarubicin
|
DCXJSUJ
|
Nystatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Olanzapine + Idarubicin
|
DC6XZO1
|
Olanzapine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Olaparib + Idarubicin
|
DCP5S96
|
Olaparib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Omacetaxine mepesuccinate + Idarubicin
|
DCFJYOV
|
Omacetaxine mepesuccinate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Omaveloxolone + Idarubicin
|
DCHQ57O
|
Omaveloxolone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Omeprazole + Idarubicin
|
DCQ8LGC
|
Omeprazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Omigapil + Idarubicin
|
DCXX2IO
|
Omigapil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Orotic acid + Idarubicin
|
DC9KDHO
|
Orotic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
OSI-027 + Idarubicin
|
DCTVT57
|
OSI-027
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
OSI-930 + Idarubicin
|
DCDYQYG
|
OSI-930
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ospemifene + Idarubicin
|
DCWX9IU
|
Ospemifene
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Otilonium bromide + Idarubicin
|
DCAFJK9
|
Otilonium bromide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Oxamflatin + Idarubicin
|
DCJ2QNF
|
Oxamflatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Oxfendazole + Idarubicin
|
DCDH3R5
|
Oxfendazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Oxyphenbutazone + Idarubicin
|
DCO92ZN
|
Oxyphenbutazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
PAC1 + Idarubicin
|
DCREEYH
|
PAC1
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PAT-001 + Idarubicin
|
DCG9WE1
|
PAT-001
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pazopanib + Idarubicin
|
DCHAL3X
|
Pazopanib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PD-0325901 + Idarubicin
|
DC3NU0M
|
PD-0325901
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Penicillamine + Idarubicin
|
DCGLLP7
|
Penicillamine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pepstatin + Idarubicin
|
DCQKHHW
|
Pepstatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Peramivir + Idarubicin
|
DC0IPCV
|
Peramivir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-02545920 + Idarubicin
|
DCBGFK2
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
PF-02545920 + Idarubicin
|
DCONV0K
|
PF-02545920
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-03772304 + Idarubicin
|
DCII6T2
|
PF-03772304
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-04691502 + Idarubicin
|
DC9MFCR
|
PF-04691502
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-228 + Idarubicin
|
DC597G1
|
PF-228
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-4217903 + Idarubicin
|
DCNH9CV
|
PF-4217903
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-4418948 + Idarubicin
|
DCJRIQ7
|
PF-4418948
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-4708671 + Idarubicin
|
DCW3CWW
|
PF-4708671
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-477736 + Idarubicin
|
DCDSOZQ
|
PF-477736
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF-562271 + Idarubicin
|
DCK4YJ1
|
PF-562271
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PF3845 + Idarubicin
|
DC03J4P
|
PF3845
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PH-797804 + Idarubicin
|
DC5R1N6
|
PH-797804
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PHA-739358 + Idarubicin
|
DC1SUTE
|
PHA-739358
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
PHA-739358 + Idarubicin
|
DC3T9ZY
|
PHA-739358
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PHA-793887 + Idarubicin
|
DC0WHOZ
|
PHA-793887
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Phensuximide + Idarubicin
|
DC150DB
|
Phensuximide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Phensuximide + Idarubicin
|
DCFAMO3
|
Phensuximide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PHT-427 + Idarubicin
|
DCEYT02
|
PHT-427
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PI-103 + Idarubicin
|
DCBVWPT
|
PI-103
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Picoplatin + Idarubicin
|
DCEKTE2
|
Picoplatin
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
Picoplatin + Idarubicin
|
DCXA09B
|
Picoplatin
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
Picoplatin + Idarubicin
|
DCR5PN8
|
Picoplatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Picoplatin + Idarubicin
|
DCX3TV5
|
Picoplatin
|
Glioma (Cell Line: SF-295)
|
[3] |
Picoplatin + Idarubicin
|
DCXEOXT
|
Picoplatin
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
Picoplatin + Idarubicin
|
DCLC14G
|
Picoplatin
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
Picoplatin + Idarubicin
|
DCFADXK
|
Picoplatin
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
Picoplatin + Idarubicin
|
DCRIPRT
|
Picoplatin
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
Picoplatin + Idarubicin
|
DC283XI
|
Picoplatin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
Picoplatin + Idarubicin
|
DCLWFWN
|
Picoplatin
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[5] |
Picoplatin + Idarubicin
|
DC0CNKO
|
Picoplatin
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[5] |
Picoplatin + Idarubicin
|
DC40G82
|
Picoplatin
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
Picoplatin + Idarubicin
|
DC0WOVR
|
Picoplatin
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
Picoplatin + Idarubicin
|
DCJI9IV
|
Picoplatin
|
Prostate carcinoma (Cell Line: PC-3)
|
[5] |
Pitavastatin calcium + Idarubicin
|
DC83WRJ
|
Pitavastatin calcium
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pizotyline + Idarubicin
|
DCEWGQ1
|
Pizotyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
PLX-4720 + Idarubicin
|
DCRTJTG
|
PLX-4720
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PMID28460551-Compound-2 + Idarubicin
|
DCG1V7Z
|
PMID28460551-Compound-2
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
PMID28460551-Compound-2 + Idarubicin
|
DCZIN5P
|
PMID28460551-Compound-2
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PMID28460551-Compound-2 + Idarubicin
|
DCKK333
|
PMID28460551-Compound-2
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289)
|
[4] |
PMID28460551-Compound-2 + Idarubicin
|
DCHJAX8
|
PMID28460551-Compound-2
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DC3LG5Y
|
PMID28460551-Compound-2
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DCWNWOX
|
PMID28460551-Compound-2
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DCY57A0
|
PMID28460551-Compound-2
|
Malignant melanoma (Cell Line: A375)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DCN21WR
|
PMID28460551-Compound-2
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DC4FWYZ
|
PMID28460551-Compound-2
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DCWKRN5
|
PMID28460551-Compound-2
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
PMID28460551-Compound-2 + Idarubicin
|
DCO0S10
|
PMID28460551-Compound-2
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
PMID28870136-Compound-43 + Idarubicin
|
DCDOYV5
|
PMID28870136-Compound-43
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
PNU-120596 + Idarubicin
|
DCUPIQW
|
PNU-120596
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pomalidomide + Idarubicin
|
DCGC3IS
|
Pomalidomide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Prasugrel + Idarubicin
|
DCJ1L2W
|
Prasugrel
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pravastatin + Idarubicin
|
DCEW84I
|
Pravastatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Prednisolone + Idarubicin
|
DCUX4SM
|
Prednisolone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pretomanid + Idarubicin
|
DCC13K3
|
Pretomanid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Primidone + Idarubicin
|
DCS7HL6
|
Primidone
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Procarbazine + Idarubicin
|
DCX82IP
|
Procarbazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Propylthiouracil + Idarubicin
|
DCMJMKB
|
Propylthiouracil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Prothionamide + Idarubicin
|
DC05KDL
|
Prothionamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Pyrazinamide + Idarubicin
|
DCJ5QKU
|
Pyrazinamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Quinine + Idarubicin
|
DCSZBO4
|
Quinine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
R-roscovitine + Idarubicin
|
DCM3627
|
R-roscovitine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
R0-93877 + Idarubicin
|
DCOLGGH
|
R0-93877
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rabeprazole + Idarubicin
|
DCZT7UW
|
Rabeprazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Racecadotril + Idarubicin
|
DC4CCU9
|
Racecadotril
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Raloxifene + Idarubicin
|
DCDAD9A
|
Raloxifene
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Raloxifene + Idarubicin
|
DCUZPTT
|
Raloxifene
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
Raloxifene + Idarubicin
|
DCPB59K
|
Raloxifene
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[5] |
Raltegravir + Idarubicin
|
DC1N5VV
|
Raltegravir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ramelteon + Idarubicin
|
DC8S43D
|
Ramelteon
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ramipril + Idarubicin
|
DC0DODJ
|
Ramipril
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rebamipide + Idarubicin
|
DCBZOVQ
|
Rebamipide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Relenza + Idarubicin
|
DCUMK36
|
Relenza
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Repaglinide + Idarubicin
|
DC20FP1
|
Repaglinide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Resveratrol + Idarubicin
|
DCTMWZY
|
Resveratrol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
RG7853 + Idarubicin
|
DC9P992
|
RG7853
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ribavirin-TP + Idarubicin
|
DCXX1CR
|
Ribavirin-TP
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ribitol + Idarubicin
|
DCMXOFM
|
Ribitol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rifabutin + Idarubicin
|
DCSDOMO
|
Rifabutin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rifampin + Idarubicin
|
DCAU26F
|
Rifampin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rigosertib + Idarubicin
|
DCH070R
|
Rigosertib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rimantadine + Idarubicin
|
DCJ7DTP
|
Rimantadine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ritonavir + Idarubicin
|
DCT1XQN
|
Ritonavir
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rivaroxaban + Idarubicin
|
DCP2O5G
|
Rivaroxaban
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rofecoxib + Idarubicin
|
DCCFU6Y
|
Rofecoxib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Roxithromycin + Idarubicin
|
DCX7CIZ
|
Roxithromycin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
RP101 + Idarubicin
|
DCLB9N5
|
RP101
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
RTB101 + Idarubicin
|
DCV9N5G
|
RTB101
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Rufinamide + Idarubicin
|
DCPGGGV
|
Rufinamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Ruxolitinib + Idarubicin
|
DCYP1IP
|
Ruxolitinib
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
Ruxolitinib + Idarubicin
|
DCQU3EL
|
Ruxolitinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SCH 727965 + Idarubicin
|
DC80MMZ
|
SCH 727965
|
Carcinoma (Cell Line: OV90)
|
[4] |
SCH 727965 + Idarubicin
|
DCREPHS
|
SCH 727965
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
SCH 727965 + Idarubicin
|
DCNFQCE
|
SCH 727965
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
SCH 727965 + Idarubicin
|
DC0F6BE
|
SCH 727965
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
SCH 727965 + Idarubicin
|
DC6050G
|
SCH 727965
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
SCH 727965 + Idarubicin
|
DCIL0Q7
|
SCH 727965
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
SCH 727965 + Idarubicin
|
DCUMWSL
|
SCH 727965
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
SCH 727965 + Idarubicin
|
DCMS3G1
|
SCH 727965
|
Malignant melanoma (Cell Line: A375)
|
[5] |
SCH 727965 + Idarubicin
|
DCDNCMR
|
SCH 727965
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
SCH 727965 + Idarubicin
|
DCNW4H8
|
SCH 727965
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
SCH-900776 + Idarubicin
|
DCHVXC5
|
SCH-900776
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Secnidazole + Idarubicin
|
DC52HM3
|
Secnidazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Selinexor + Idarubicin
|
DC1FKPA
|
Selinexor
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Seratrodast + Idarubicin
|
DCQLG9R
|
Seratrodast
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Seviteronel + Idarubicin
|
DC38YM3
|
Seviteronel
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sgx523 + Idarubicin
|
DC11ETC
|
Sgx523
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sildenafil citrate + Idarubicin
|
DC298CN
|
Sildenafil citrate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Silver sulfadiazine + Idarubicin
|
DCXYW9T
|
Silver sulfadiazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Silver sulfadiazine + Idarubicin
|
DCTJX5D
|
Silver sulfadiazine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Simvastatin + Idarubicin
|
DCU0FJ5
|
Simvastatin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SINOMENINE + Idarubicin
|
DCIALJ7
|
SINOMENINE
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sirolimus + Idarubicin
|
DCOUAVK
|
Sirolimus
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sitagliptin + Idarubicin
|
DCBKMB1
|
Sitagliptin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SL-327 + Idarubicin
|
DC5CNNV
|
SL-327
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SNX-2112 + Idarubicin
|
DCW43QB
|
SNX-2112
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sorafenib + Idarubicin
|
DCYWNXI
|
Sorafenib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Sorafenib + Idarubicin
|
DC7YWQF
|
Sorafenib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Spectinomycin + Idarubicin
|
DCISXCW
|
Spectinomycin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SR9011 + Idarubicin
|
DCFL38K
|
SR9011
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
STF-62247 + Idarubicin
|
DC7XYDK
|
STF-62247
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Streptomycin + Idarubicin
|
DC7XJE6
|
Streptomycin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
STX 64 + Idarubicin
|
DCWEKQ6
|
STX 64
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sulfamethizole + Idarubicin
|
DC2UP3S
|
Sulfamethizole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sulfanilamide + Idarubicin
|
DC5AZOF
|
Sulfanilamide
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sulfapyridine + Idarubicin
|
DC81HVT
|
Sulfapyridine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Sulfapyridine + Idarubicin
|
DCYP2V2
|
Sulfapyridine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sulfisoxazole + Idarubicin
|
DCTP2SE
|
Sulfisoxazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sulindac + Idarubicin
|
DCA8Z72
|
Sulindac
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Sulphadoxine + Idarubicin
|
DCV69YA
|
Sulphadoxine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SY-1425 + Idarubicin
|
DCBFXXZ
|
SY-1425
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
SY-1425 + Idarubicin
|
DCV2PN5
|
SY-1425
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
SY-1425 + Idarubicin
|
DCNNJKT
|
SY-1425
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
SY-1425 + Idarubicin
|
DCD6OLK
|
SY-1425
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[5] |
Tacedinaline + Idarubicin
|
DC56CG0
|
Tacedinaline
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tacrine + Idarubicin
|
DCMUMWF
|
Tacrine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tadalafil + Idarubicin
|
DCDRCVD
|
Tadalafil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TAK-285 + Idarubicin
|
DCIDQRA
|
TAK-285
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TAK-715 + Idarubicin
|
DC42RU5
|
TAK-715
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TAK-733 + Idarubicin
|
DC3JR05
|
TAK-733
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TAK-901 + Idarubicin
|
DCDF94I
|
TAK-901
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Taltirelin + Idarubicin
|
DC9VUDZ
|
Taltirelin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Taxol + Idarubicin
|
DCGI7LS
|
Taxol
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[3] |
Taxol + Idarubicin
|
DC87NUD
|
Taxol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Taxol + Idarubicin
|
DCLTNYH
|
Taxol
|
Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)
|
[4] |
Taxol + Idarubicin
|
DC68120
|
Taxol
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Taxol + Idarubicin
|
DC1JH8U
|
Taxol
|
Adenocarcinoma (Cell Line: SW-620)
|
[5] |
Taxol + Idarubicin
|
DCWYFZ8
|
Taxol
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Taxol + Idarubicin
|
DCK9YX7
|
Taxol
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
Taxol + Idarubicin
|
DCU40RS
|
Taxol
|
Malignant melanoma (Cell Line: A375)
|
[5] |
Taxol + Idarubicin
|
DCHYJ17
|
Taxol
|
Malignant melanoma (Cell Line: RPMI7951)
|
[5] |
Taxol + Idarubicin
|
DCPDAZJ
|
Taxol
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Taxol + Idarubicin
|
DCUHPGI
|
Taxol
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Telithromycin + Idarubicin
|
DCLNZCD
|
Telithromycin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Telmisartan + Idarubicin
|
DC4SG82
|
Telmisartan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TEM + Idarubicin
|
DC268OV
|
TEM
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Temsirolimus + Idarubicin
|
DCLVWKC
|
Temsirolimus
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Testosterone + Idarubicin
|
DCZYYU8
|
Testosterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Tetrahydrouridine + Idarubicin
|
DCF6CTY
|
Tetrahydrouridine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TG100-115 + Idarubicin
|
DCLWJQH
|
TG100-115
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Thiamphenicol + Idarubicin
|
DCHJEJS
|
Thiamphenicol
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Thioguanine + Idarubicin
|
DCT8I8Q
|
Thioguanine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Thioguanine + Idarubicin
|
DCYRC59
|
Thioguanine
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
Thioguanine + Idarubicin
|
DC0OQDF
|
Thioguanine
|
Glioma (Cell Line: SF-539)
|
[3] |
Thioguanine + Idarubicin
|
DCS9WXE
|
Thioguanine
|
Glioma (Cell Line: SF-295)
|
[3] |
Tideglusib + Idarubicin
|
DCU8EJL
|
Tideglusib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tindamax + Idarubicin
|
DCA052Q
|
Tindamax
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TKI258 + Idarubicin
|
DCPSY7B
|
TKI258
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TNX-102 + Idarubicin
|
DCPU9US
|
TNX-102
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tofacitinib + Idarubicin
|
DCJFT42
|
Tofacitinib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tolazoline + Idarubicin
|
DC9HT9R
|
Tolazoline
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tolnaftate + Idarubicin
|
DC1OCON
|
Tolnaftate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tolvaptan + Idarubicin
|
DC55D9F
|
Tolvaptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Tolvaptan + Idarubicin
|
DC88O48
|
Tolvaptan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Topotecan + Idarubicin
|
DCSWMTA
|
Topotecan
|
Adenocarcinoma (Cell Line: A427)
|
[5] |
Topotecan + Idarubicin
|
DCVWMMD
|
Topotecan
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Topotecan + Idarubicin
|
DCV9NZM
|
Topotecan
|
Amelanotic melanoma (Cell Line: A2058)
|
[5] |
Topotecan + Idarubicin
|
DCAY5RM
|
Topotecan
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Topotecan + Idarubicin
|
DCUHP8W
|
Topotecan
|
Glioma (Cell Line: SF-268)
|
[5] |
Topotecan + Idarubicin
|
DCAKMR3
|
Topotecan
|
Melanoma (Cell Line: UACC-257)
|
[5] |
Topotecan + Idarubicin
|
DCPDYKV
|
Topotecan
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
Topotecan + Idarubicin
|
DCOSH7A
|
Topotecan
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
Topotecan + Idarubicin
|
DCFCZ6D
|
Topotecan
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Topotecan + Idarubicin
|
DCJY2PX
|
Topotecan
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
Topotecan + Idarubicin
|
DCHUY55
|
Topotecan
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
Torcetrapib + Idarubicin
|
DC18QC2
|
Torcetrapib
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
TPCA-1 + Idarubicin
|
DCJVTTH
|
TPCA-1
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tranexamic acid + Idarubicin
|
DCHVTP0
|
Tranexamic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tranilast + Idarubicin
|
DC6BP54
|
Tranilast
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Travoprost + Idarubicin
|
DC26D5T
|
Travoprost
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Tretinoin + Idarubicin
|
DCIU1NE
|
Tretinoin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Triapine + Idarubicin
|
DCFG4I5
|
Triapine
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Triciribine + Idarubicin
|
DC5GMQ0
|
Triciribine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Triflupromazine + Idarubicin
|
DC8SXAJ
|
Triflupromazine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Trifluridine + Idarubicin
|
DCLMY4A
|
Trifluridine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Trifluridine + Idarubicin
|
DCUYPYZ
|
Trifluridine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
Trifluridine + Idarubicin
|
DCBWAJ9
|
Trifluridine
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
Trimethobenzamide + Idarubicin
|
DCTBKRV
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Trioxsalen + Idarubicin
|
DCKX7GV
|
Trioxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Tropisetron + Idarubicin
|
DCZXYGD
|
Tropisetron
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
TW-37 + Idarubicin
|
DCDRM1U
|
TW-37
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Uracil mustard + Idarubicin
|
DCZDDB2
|
Uracil mustard
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
Uridine + Idarubicin
|
DCUL5U6
|
Uridine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Uridine triacetate + Idarubicin
|
DC3QGB7
|
Uridine triacetate
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Ursodeoxycholic acid + Idarubicin
|
DCKWE65
|
Ursodeoxycholic acid
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Valproic Acid + Idarubicin
|
DC4U3YB
|
Valproic Acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Vandetanib + Idarubicin
|
DCXU3HF
|
Vandetanib
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
Vandetanib + Idarubicin
|
DCEBMPJ
|
Vandetanib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Vandetanib + Idarubicin
|
DCBF7MJ
|
Vandetanib
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Vandetanib + Idarubicin
|
DCLT53M
|
Vandetanib
|
Glioma (Cell Line: SF-268)
|
[5] |
Vardenafil + Idarubicin
|
DCZO6JY
|
Vardenafil
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
VE-821 + Idarubicin
|
DCPHXQQ
|
VE-821
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Vemurafenib + Idarubicin
|
DCXR7F8
|
Vemurafenib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Vemurafenib + Idarubicin
|
DCKJGUB
|
Vemurafenib
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
Vemurafenib + Idarubicin
|
DC5G4R1
|
Vemurafenib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[5] |
Vemurafenib + Idarubicin
|
DCMOAAC
|
Vemurafenib
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Vemurafenib + Idarubicin
|
DCCUXPA
|
Vemurafenib
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
VESNARINONE + Idarubicin
|
DCHOYYZ
|
VESNARINONE
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Vinblastine + Idarubicin
|
DCTL9LV
|
Vinblastine
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[3] |
Vinblastine + Idarubicin
|
DCRBTGR
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Vinblastine + Idarubicin
|
DCHJ841
|
Vinblastine
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Vincristine + Idarubicin
|
DCK3Q4L
|
Vincristine
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
Vincristine + Idarubicin
|
DC8U37M
|
Vincristine
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
Vincristine + Idarubicin
|
DCTPOLX
|
Vincristine
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
Vincristine + Idarubicin
|
DCWKI9T
|
Vincristine
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
Vincristine + Idarubicin
|
DCYDFDL
|
Vincristine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
Vincristine + Idarubicin
|
DCKVGQF
|
Vincristine
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[3] |
Vincristine + Idarubicin
|
DCR53AX
|
Vincristine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
Vincristine + Idarubicin
|
DCYRGFI
|
Vincristine
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
Vinorelbine + Idarubicin
|
DCYWDAZ
|
Vinorelbine
|
Adenocarcinoma (Cell Line: NCIH2122)
|
[5] |
Vinorelbine + Idarubicin
|
DCBIS65
|
Vinorelbine
|
Adenocarcinoma (Cell Line: COLO320DM)
|
[5] |
Vinorelbine + Idarubicin
|
DC1G7CM
|
Vinorelbine
|
Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)
|
[5] |
Vinorelbine + Idarubicin
|
DCNNKFU
|
Vinorelbine
|
Mesothelioma (Cell Line: MSTO)
|
[5] |
Vinorelbine + Idarubicin
|
DC72208
|
Vinorelbine
|
Ovarian endometrioid adenocarcinoma (Cell Line: A2780)
|
[5] |
Vismodegib + Idarubicin
|
DCOC4UR
|
Vismodegib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
Vismodegib + Idarubicin
|
DCCTDV0
|
Vismodegib
|
Glioblastoma? (Cell Line: T98G)
|
[5] |
Vitamin B3 + Idarubicin
|
DCWTF3Z
|
Vitamin B3
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Voriconazole + Idarubicin
|
DCDPCSJ
|
Voriconazole
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Vorinostat + Idarubicin
|
DCYVVIZ
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Vorinostat + Idarubicin
|
DC01ROC
|
Vorinostat
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
VR-776 + Idarubicin
|
DC06MY1
|
VR-776
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
VU0357121 + Idarubicin
|
DCQ2FVB
|
VU0357121
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
VX-702 + Idarubicin
|
DCNCGP1
|
VX-702
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
VX-745 + Idarubicin
|
DC2HX8X
|
VX-745
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
WHI-P154 + Idarubicin
|
DCVU2E5
|
WHI-P154
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Wortmannin + Idarubicin
|
DCE88B8
|
Wortmannin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
WZ4003 + Idarubicin
|
DCLS8YG
|
WZ4003
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
XCT790 + Idarubicin
|
DC5H4R7
|
XCT790
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Y-39983 + Idarubicin
|
DCTR7H6
|
Y-39983
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
YM-511 + Idarubicin
|
DCTXGOD
|
YM-511
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Yn-968D1 + Idarubicin
|
DCR0LEZ
|
Yn-968D1
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Zaltoprofen + Idarubicin
|
DC3AW8R
|
Zaltoprofen
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Zarnestra + Idarubicin
|
DCWBFZH
|
Zarnestra
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Zileuton + Idarubicin
|
DC393GT
|
Zileuton
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
Zolmitriptan + Idarubicin
|
DCUWC0J
|
Zolmitriptan
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
------------------------------------------------------------------------------------ |
|
|
|
|